416 related articles for article (PubMed ID: 19356045)
1. Involvement of P-glycoprotein and multidrug resistance associated protein 1 in the transport of tanshinone IIB, a primary active diterpenoid quinone from the roots of Salvia miltiorrhiza, across the blood-brain barrier.
Zhou ZW; Chen X; Liang J; Yu XY; Wen JY; Zhou SF
Drug Metab Lett; 2007 Aug; 1(3):205-17. PubMed ID: 19356045
[TBL] [Abstract][Full Text] [Related]
2. Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier.
Yu XY; Lin SG; Chen X; Zhou ZW; Liang J; Duan W; Chowbay B; Wen JY; Chan E; Cao J; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):365-78. PubMed ID: 17504224
[TBL] [Abstract][Full Text] [Related]
3. Role of P-glycoprotein in restricting the brain penetration of tanshinone IIA, a major active constituent from the root of Salvia miltiorrhiza Bunge, across the blood-brain barrier.
Chen X; Zhou ZW; Xue CC; Li XX; Zhou SF
Xenobiotica; 2007 Jun; 37(6):635-78. PubMed ID: 17614009
[TBL] [Abstract][Full Text] [Related]
4. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
5. Role of ATP-binding cassette drug transporters in the intestinal absorption of tanshinone IIB, one of the major active diterpenoids from the root of Salvia miltiorrhiza.
Yu XY; Zhou ZW; Lin SG; Chen X; Yu XQ; Liang J; Duan W; Wen JY; Li XT; Zhou SF
Xenobiotica; 2007 Apr; 37(4):375-415. PubMed ID: 17455112
[TBL] [Abstract][Full Text] [Related]
6. Role of P-glycoprotein in limiting the brain penetration of glabridin, an active isoflavan from the root of Glycyrrhiza glabra.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Yu XQ; Chowbay B; Wen JY; Duan W; Chan E; Li XT; Cao J; Li CG; Xue CC; Zhou SF
Pharm Res; 2007 Sep; 24(9):1668-90. PubMed ID: 17551811
[TBL] [Abstract][Full Text] [Related]
7. Role of P-glycoprotein in the transport of tanshinone I, one active triterpenoid from Salvia miltiorrhiza.
Li XX; Zhou ZW; Zhou SF
Drug Metab Lett; 2008 Aug; 2(3):223-30. PubMed ID: 19356097
[TBL] [Abstract][Full Text] [Related]
8. Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier.
Bourasset F; Cisternino S; Temsamani J; Scherrmann JM
J Neurochem; 2003 Sep; 86(6):1564-7. PubMed ID: 12950465
[TBL] [Abstract][Full Text] [Related]
9. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.
Cisternino S; Mercier C; Bourasset F; Roux F; Scherrmann JM
Cancer Res; 2004 May; 64(9):3296-301. PubMed ID: 15126373
[TBL] [Abstract][Full Text] [Related]
10. (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP.
Römermann K; Wanek T; Bankstahl M; Bankstahl JP; Fedrowitz M; Müller M; Löscher W; Kuntner C; Langer O
Nucl Med Biol; 2013 Oct; 40(7):873-8. PubMed ID: 23845421
[TBL] [Abstract][Full Text] [Related]
11. Roles of P-glycoprotein and multidrug resistance protein in transporting para-aminosalicylic acid and its N-acetylated metabolite in mice brain.
Hong L; Xu C; O'Neal S; Bi HC; Huang M; Zheng W; Zeng S
Acta Pharmacol Sin; 2014 Dec; 35(12):1577-85. PubMed ID: 25418377
[TBL] [Abstract][Full Text] [Related]
12. Effect of P-Glycoprotein on the Blood-Brain Barrier Transport of the Major Active Constituents of
Fang J; He Y; Cao Y; Shi Y; Wang H; Hong Z; Chai Y
ACS Chem Neurosci; 2023 Feb; 14(4):766-772. PubMed ID: 36704945
[No Abstract] [Full Text] [Related]
13. Involvement of multidrug resistance associated protein 1 (Mrp1) in the efflux transport of 17beta estradiol-D-17beta-glucuronide (E217betaG) across the blood-brain barrier.
Sugiyama D; Kusuhara H; Lee YJ; Sugiyama Y
Pharm Res; 2003 Sep; 20(9):1394-400. PubMed ID: 14567633
[TBL] [Abstract][Full Text] [Related]
14. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier.
Bihorel S; Camenisch G; Lemaire M; Scherrmann JM
J Neurochem; 2007 Sep; 102(6):1749-1757. PubMed ID: 17696988
[TBL] [Abstract][Full Text] [Related]
15. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S
J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785
[TBL] [Abstract][Full Text] [Related]
16. Saturable active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier leads to nonlinear distribution of elacridar to the central nervous system.
Sane R; Agarwal S; Mittapalli RK; Elmquist WF
J Pharmacol Exp Ther; 2013 Apr; 345(1):111-24. PubMed ID: 23397054
[TBL] [Abstract][Full Text] [Related]
17. Apparent lack of Mrp1-mediated efflux at the luminal side of mouse blood-brain barrier endothelial cells.
Cisternino S; Rousselle C; Lorico A; Rappa G; Scherrmann JM
Pharm Res; 2003 Jun; 20(6):904-9. PubMed ID: 12817896
[TBL] [Abstract][Full Text] [Related]
18. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.
Roberts LM; Black DS; Raman C; Woodford K; Zhou M; Haggerty JE; Yan AT; Cwirla SE; Grindstaff KK
Neuroscience; 2008 Aug; 155(2):423-38. PubMed ID: 18619525
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier.
Narang VS; Fraga C; Kumar N; Shen J; Throm S; Stewart CF; Waters CM
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C440-50. PubMed ID: 18524938
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein and breast cancer resistance protein affect disposition of tandutinib, a tyrosine kinase inhibitor.
Yang JJ; Milton MN; Yu S; Liao M; Liu N; Wu JT; Gan L; Balani SK; Lee FW; Prakash S; Xia CQ
Drug Metab Lett; 2010 Dec; 4(4):201-12. PubMed ID: 20670210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
